Friday, August 12, 2016

Angiotensin II as a vasopressor (ATHOS 3 Trial)

Resultado de imagen de MAryland CC project
Maryland CC Project - By Jim Lantry
"Today we are very excited to host Dr. Lakhmir S. Chawla, nephrologist, intensivist, and international expert on the management of shock. Dr. Chawla has recently taken a sabbatical from his position as Professor of Critical Care Medicine, George Washington U to become the Chief Medical Officer of La Jolla Pharmaceuticals. It in this role he investigates an old and forgotten friend in the treatment of hypotension, and has become the chief researcher for the ATHOS (Angiotensin II for the Treatment of High-Output Shock) 3 trial. Today he takes a fascinating look at the way we treat shock-induced hypotension and asks one simple question: Can’t we do better?"
Screen Shot 2016-08-09 at 7.37.39 PM                 Chawla